Electromed, Inc. (ELMD)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

The chart shows the growth of an initial investment of $10,000 in Electromed, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.

Electromed, Inc. (ELMD) has returned -19.61% so far this year and -1.89% over the past 12 months. Looking at the last ten years, ELMD has achieved an annualized return of 19.09%, outperforming the S&P 500 Index benchmark, which averaged 12.16% per year.

Based on dividend-adjusted daily data since Aug 13, 2010, ELMD's average daily return is +0.13%, while the average monthly return is +2.86%. At this rate, your investment would double in approximately 2.0 years.

Historically, 51% of months were positive and 49% were negative. The best month was Dec 2013 with a return of +208.6%, while the worst month was Jan 2014 at -50.0%. The longest winning streak lasted 7 consecutive months, and the longest losing streak was 11 months.

On a daily basis, ELMD closed higher 45% of trading days. The best single day was Dec 30, 2013 with a return of +106.9%, while the worst single day was Nov 8, 2017 at -18.3%.

Electromed, Inc. has an annualized alpha of 27.08%, beta of 0.59, and R² of 0.02 versus S&P 500 Index. Calculated based on daily prices since August 16, 2010.

• This stock participates in less of S&P 500 Index's moves in both directions, but captures a larger share of gains (64.55%) than losses (49.30%) — typical of diversified or defensive assets.
• Beta of 0.59 may look defensive, but with R² of 0.02 this stock is largely uncorrelated with S&P 500 Index — low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
• R² of 0.02 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

ELMD ranks 38 for risk / return — below 38% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.

The table below present risk-adjusted performance metrics for Electromed, Inc. (ELMD) and compare them to a chosen benchmark (S&P 500 Index).

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Electromed, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Electromed, Inc. was 78.65%, occurring on Sep 16, 2013. Recovery took 617 trading sessions.

The current Electromed, Inc. drawdown is 33.93%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Electromed, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Electromed, Inc. is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.